Riskpilot← Back to searchSign inGet full accessBEST HELSE AS
ASActiveOrg 993061107Kongsveien 104, 1177 OsloOther human health activities n.e.c. · NACE 8699Est. 200841 employeeswww.bestnordstrand.no
Revenue 2025
NOK 46,3M
+2% vs 2024
EBITDA margin
12.1%
-4% vs 2024
Equity ratio
12.3%
Financial strength
Net profit 2025
NOK 3,9M
-3% vs 2024
| Revenue | NOK 46,3M | +2% |
| EBITDA | NOK 5,6M | -4% |
| Net profit | NOK 3,9M | -3% |
| Total assets | NOK 15M | -19% |
| Equity | NOK 1,9M | -35% |
| Employees | 41 | — |
Legal name
BEST HELSE AS
Org number
993061107
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
11. september 2008
Share capital
NOK 275 319
Employees
41 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Å tilby helsetjenester og andre tjenester som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Kongsveien 104, 1177 Oslo
Website
www.bestnordstrand.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 39 986 | 38 297 | 42 880 | 45 371 | 46 333 |
| Staff expenses | −11 949 | −13 571 | −17 079 | −19 432 | −20 511 |
| EBITDA | 8 175 | 5 533 | 5 734 | 5 833 | 5 624 |
| Depreciation & amort. | −1 156 | −1 128 | −750 | −845 | −751 |
| EBIT | 7 019 | 4 404 | 4 984 | 4 988 | 4 873 |
| Net financials | −2 | −3 | −0 | 162 | 132 |
| Profit before tax | 7 017 | 4 402 | 4 984 | 5 151 | 5 005 |
| Tax | 1 546 | 969 | 1 097 | 1 133 | 1 101 |
| Net profit | 5 470 | 3 433 | 3 887 | 4 017 | 3 904 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 18 922 | 16 530 | 18 099 | 18 492 | 15 029 |
| Equity | 5 402 | 8 835 | 6 830 | 2 847 | 1 850 |
| Long-term debt | 86 | 18 | 18 | 0 | 0 |
| Short-term debt | 13 434 | 7 677 | 11 251 | 15 645 | 13 157 |
| Total debt | 13 520 | 7 695 | 11 270 | 15 645 | 13 179 |
EBITDA margin
12.1%
This company
15.8%
Market median
-23% vs market
20212025
Equity ratio
12.3%
This company
38.2%
Market median
-68% vs market
20212025
Return on equity
211.0%
This company
18.4%
Market median
+1047% vs market
20212025
Net profit margin
8.4%
This company
8.1%
Market median
+4% vs market
20212025
Asset turnover
3.08×
This company
1.12×
Market median
+175% vs market
20212025
Debt / equity
7.12×
This company
0.62×
Market median
-1048% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ER Chief Executive Officer | Chief Executive Officer | 2008 |
IF Deputy Member | Deputy Member | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
OS | Board of Directors | 2021 |
| Chairman | 2021 | |
| Former (2) | ||
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2021 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 26.07% | 26.07% | 2024 | |
| Company | 18.09% | 18.09% | 2024 | |
| Company | 15.62% | 15.62% | 2024 | |
| Individual | 6.29% | 6.29% | 2024 | |
| Individual | 5.81% | 5.81% | 2024 | |
| Company | 4.72% | 4.72% | 2024 | |
| Company | 4.61% | 4.61% | 2024 | |
| Individual | 2.91% | 2.91% | 2024 | |
| Individual | 2.36% | 2.36% | 2024 | |
| Individual | 1.53% | 1.53% | 2024 | |
| Individual | 1.45% | 1.45% | 2024 | |
| Company | 1.45% | 1.45% | 2024 | |
| Individual | 1.45% | 1.45% | 2024 | |
| Individual | 1.09% | 1.09% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BEST HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Espen Raymond Rooth | Chief Executive Officer | 0 companies |
| Iren-Marie Fjellheim | Deputy Member | 0 companies |
| Marianne Kroken Eriksen | Board of Directors | 0 companies |
| Helene Bue | Board of Directors | 0 companies |
| Mona Skirbekk Vister | Board of Directors | 0 companies |
| Ola Sand | Board of Directors | 0 companies |
| Kristine Malm Larneng | Chairman | 0 companies |